Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: Meta-analysis of eight studies

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 4, 2012, Pages 719-722

  Smith, N L ^a,b,c   Heit, J A ^d   Tang, W ^e   Teichert, M ^f   Chasman, D I ^g   Morange, P E ^h,i   McKnight, B ^a   Pankratz, N ^h,k,l,m   Leebeek, F W G ^f   Rose, L M ^g   Amouyel, P ^g   Uitterlinden, A G ^f   Hofman, A ^f   Lathrop, M ⁿ   Lambert, J C ^h,l,m   Cushman, M ^j   De Andrade, M ^d   Folsom, A R ^e   Stricker, B H ^f   Ridker, P M ^g   Tregouet, D A ^h   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c Veterans Affairs Office of Research and Development   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h INSERM   (France)

ⁱ AIX MARSEILLE UNIVERSITY   (France)

^j UNIVERSITY OF VERMONT   (United States)

^k UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^l INSTITUT PASTEUR DE LILLE   (France)

^m UNIV LILLE   (France)

ⁿ CENTRE NATIONAL DE GÉNOTYPAGE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

F3 GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC VARIABILITY; HUMAN; LETTER; PRIORITY JOURNAL; VEIN THROMBOSIS;

FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHENOTYPE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; THROMBOPLASTIN; VENOUS THROMBOSIS;

EID: 84859180156     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04665.x     Document Type: Letter

References (22)

1. Mackman N. The many faces of tissue factor. J Thromb Haemost 2009; 7(Suppl. 1): 136-9.
2. Day SM, Reeve JL, Pedersen B, Farris DM, Myers DD, Im M, Wakefield TW, Mackman N, Fay WP. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 2005; 105: 192-8.
3. Niessen F, Schaffner F, Furlan-Freguia C, Pawlinski R, Bhattacharjee G, Chun J, Derian CK, Andrade-Gordon P, Rosen H, Ruf W. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 2008; 452: 654-8.
4. Hembrough TA, Swartz GM, Papathanassiu A, Vlasuk GP, Rote WE, Green SJ, Pribluda VS. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res 2003; 63: 2997-3000.
5. Smith NL, Huffman JE, Strachan DP, Huang J, Dehghan A, Trompet S, Lopez LM, Shin SY, Baumert J, Vitart V, Bis JC, Wild SH, Rumley A, Yang Q, Uitterlinden AG, Stott DJ, Davies G, Carter AM, Thorand B, Polasek O, et al. Genetic predictors of fibrin D-dimer levels in healthy adults. Circulation 2011; 123: 1864-72.
6. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, Rice K, Lumley T, Bis JC, Wiggins KL, Rosendaal FR, Psaty BM. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 2007; 297: 489-98.
7. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25.
8. Germain M, Saut N, Greliche N, Dina C, Lambert JC, Perret C, Cohen W, Oudot-Mellakh T, Antoni G, Alessi MC, Zelenika D, Cambien F, Tiret L, Bertrand M, Dupuy AM, Letenneur L, Lathrop M, Emmerich J, Amouyel P, Tregouet DA, et al. Genetics of venous thrombosis: insights from a new genome wide association study. PLoS ONE 2011; 6: e25581.
9. Tregouet DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Juhan-Vague I, Alessi MC, Tiret L, Lathrop M, Emmerich J, Morange PE. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009; 113: 5298-303.
10. Heit JA, Matsumoto ME, Asmann Y, Jeavons E, Armasu SM, Petterson TM, Cunningham JM, Andrade M. Imputed Genome Wide and Candidate Gene Studies Reveals Novel Genetic Variant Associated with Venous Thromboembolism (VTE). Genet Epidemiol 2010; 34: 974.
11. Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR, Witteman JC. The Rotterdam Study: objectives and design update. Eur J Epidemiol 2007; 22: 819-29.
12. Ridker PM, Chasman DI, Zee RY, Parker A, Rose L, Cook NR, Buring JE. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25000 initially healthy american women. Clin Chem 2008; 54: 249-55.
13. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty BM, Rautaharju P, Tracy RP, Weiler PG. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991; 1: 263-76.
14. The Atherosclerosis Risk in Communities (ARIC). Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129: 687-702.
15. Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003; 101: 1243-8.
16. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J. Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66, 155 cases and 91, 307 controls. Lancet 2006; 367: 651-8.
17. Lange LA, Reiner AP, Carty CL, Jenny NS, Cushman M, Lange EM. Common genetic variants associated with plasma fibrin D-dimer concentration in older European- and African-American adults. J Thromb Haemost 2008; 6: 654-9.
18. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
19. Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci U S A 1994; 91: 1396-400.
20. Carter AM, Catto AJ, Kohler HP, Ariens RA, Stickland MH, Grant PJ. alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 2000; 96: 1177-9.
21. Reiner AP, Carty CL, Carlson CS, Wan JY, Rieder MJ, Smith JD, Rice K, Fornage M, Jaquish CE, Williams OD, Tracy RP, Lewis CE, Siscovick DS, Boerwinkle E, Nickerson DA. Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Thromb Haemost 2006; 4: 1279-87.
22. Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariens RA. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation 2003; 107: 2326-30.